GL1X · GenesisL1 explorer

MolNFT v1 · #31954 · protein

Human DELTAF508 NBD1 with two solublizing mutations.

2BBT · Cystic fibrosis transmembrane conductance regulator: “Human DELTAF508 NBD1 with two solublizing mutations.”. X-ray diffraction, 2 ligands (ATP, MG), 3 pockets (best druggability 0.73). MolNFT v1 #31954 on GenesisL1: 3D structure…

PDB
2BBT
Type
protein
Length
507 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Cystic fibrosis transmembrane conductance regulator
UniProt
P13569
Ligands
ATP, MG
Pockets
3 · best druggability 0.73

Structure

x-ray diffraction · 2 distinct chains · 40% helix, 22% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ACystic fibrosis transmembrane conductance regulatorprotein24941% helix, 23% strandP13569
BCystic fibrosis transmembrane conductance regulatorprotein25840% helix, 22% strandP13569

Ligands and binding sites

  • ATP · Adenosine-5'-triphosphate · ligand · 2 copies · chains A, B
  • MG · Magnesium ion · metal · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
18070.730.7975MG, ATP
21320.450.7736MG
3880.420.7818empty

Interfaces

1 interface between chains.

  • A–B · 178 Ų buried · 1 hydrogen bond · protein-protein

Compared structures

  • 2BBT · Human deltaF508 NBD1 with two solublizing mutations. · the same entry in another collection · chain A against A, TM-score 1.00
  • P13569 · AlphaFold monomer V2.0 prediction for cystic fibrosis transmembrane conductance regulator… · a predicted model of the same protein · chain A against A, TM-score 0.94

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.